Document is current
Any future updates will be listed below
-
Authors
Horvat-Menih, Ines http://orcid.org/0000-0002-1373-6944
Li, Hao
Priest, Andrew N.
Li, Shaohang
Gill, Andrew B.
Mendichovszky, Iosif A.
Francis, Susan T.
Warren, Anne Y.
O’Carrigan, Brent
Welsh, Sarah J.
Jones, James O.
Riddick, Antony C. P.
Armitage, James N.
Mitchell, Thomas J.
Stewart, Grant D.
Gallagher, Ferdia A.
-
Funding
Funding for this research was provided by:
Cancer Research UK (RQAG/119)
- License Information
-
More Information
Article History
Received: 9 February 2024
Accepted: 25 April 2024
First Online: 10 July 2024
Declarations
:
: East of England – Cambridge East Research Ethics Committee issued Institutional Review Board approval for this study.Informed consent was obtained from all subjects involved in the study.
: Not applicable.
: GDS has received educational grants from Pfizer, AstraZeneca and Intuitive Surgical; consultancy fees from Pfizer, MSD, EUSA Pharma and CMR Surgical; Travel expenses from MSD and Pfizer; Speaker fees from Pfizer; Clinical lead (urology) National Kidney Cancer Audit and Topic Advisor for the NICE kidney cancer guideline. SJW is a founder and director of Pinto Medical Consultancy. FAG is a member of the Scientific Editorial Board for <i>European Radiology Experimental</i> (Section Editor, Magnetic resonance) and has research grants from GlaxoSmithKline and AstraZeneca, research support from GE Healthcare, and has consulted for AstraZeneca on behalf of the University of Cambridge. They have not participated in the selection nor review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
